Low HER2 expression is a predictor of poor prognosis in stage I triple-negative breast cancer

Overview of attention for article published in Frontiers in oncology, March 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

twitter: 3 X users

Readers on

mendeley: 10 Mendeley

Summary X

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 24,533 followers.

Low HER2 expression is a predictor of poor prognosis in stage I triple-negative breast cancer https://t.co/VtAdyCWr7K https://t.co/ZghIbFc63J

14 Apr 2023

Reply Repost Favourite

RT @FrontOncology: New research: Low HER2 expression is a predictor of poor prognosis in stage I triple-negative breast cancer: Introductio…

08 Apr 2023

Reply Repost Favourite

New research: Low HER2 expression is a predictor of poor prognosis in stage I triple-negative breast cancer: Introduction Triple-negative breast cancer (TNBC) is negative for hormone receptors and human epidermal growth factor receptor 2… https://t.co/EwX

07 Apr 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.